Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · IEX Real-Time Price · USD
8.24
-0.70 (-7.83%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Cogent Biosciences Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Cogent Biosciences stock have an average target of 14.67, with a low estimate of 8.00 and a high estimate of 20. The average target predicts an increase of 78.03% from the current stock price of 8.24.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for COGT stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 4 | 4 | 4 | 4 | 3 |
Buy | 4 | 2 | 2 | 2 | 2 | 1 |
Hold | 1 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 8 | 8 | 8 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +118.45% | Jun 27, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +130.58% | Jun 17, 2024 |
Needham | Needham | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +118.45% | Jun 17, 2024 |
Wedbush | Wedbush | Hold Reiterates $10 | Hold | Reiterates | $10 | +21.36% | May 24, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +130.58% | May 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
1.80M
EPS This Year
-2.33
from -2.42
EPS Next Year
-2.29
from -2.33
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | 11.1M | 221.6M | 634.3M | 614.5M |
Avg | n/a | 1.8M | 85.3M | 248.0M | 437.8M |
Low | n/a | n/a | 6.2M | 73.6M | 225.1M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 12,194.7% | 644.0% | 147.8% |
Avg | - | - | 4,631.3% | 190.8% | 76.5% |
Low | - | - | 245.2% | -13.7% | -9.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.64 | -1.52 | -0.89 | 0.71 | 1.54 |
Avg | -2.33 | -2.29 | -1.55 | 0.01 | 1.50 |
Low | -2.58 | -2.83 | -2.52 | -0.44 | 1.44 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 22,485.6% |
Avg | - | - | - | - | 21,840.3% |
Low | - | - | - | - | 20,979.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.